morphiceptin has been researched along with Abdominal Pain in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Fichna, J; Mazur, M; Olczak, J; Szymaszkiewicz, A; Włodarczyk, J; Zielińska, M | 1 |
Chen, C; Cygankiewicz, AI; Fichna, J; Krajewska, WM; Małecka-Panas, E; Mokrowiecka, A; Sałaga, M; Wlaź, P; Zakrzewski, PK; Zielińska, M | 1 |
2 other study(ies) available for morphiceptin and Abdominal Pain
Article | Year |
---|---|
Cyclic derivatives of morphiceptin possess anti-transit effect in the gastrointestinal tract and alleviate abdominal pain in mice.
Topics: Abdominal Pain; Animals; Endorphins; Gastrointestinal Tract; Gastrointestinal Transit; Injections, Intraperitoneal; Male; Mice; Mice, Inbred BALB C; Peptides, Cyclic; Structure-Activity Relationship | 2020 |
Orally administered novel cyclic pentapeptide P-317 alleviates symptoms of diarrhoea-predominant irritable bowel syndrome.
Topics: Abdominal Pain; Administration, Oral; Adult; Aged; Analgesics; Animals; Antidiarrheals; Case-Control Studies; Colon; Diarrhea; Disease Models, Animal; Endorphins; Gastrointestinal Transit; Humans; Ileum; Irritable Bowel Syndrome; Male; Mice, Inbred BALB C; Middle Aged; Muscle Contraction; Muscle, Smooth; Mustard Plant; Plant Oils; Receptors, Opioid; Young Adult | 2015 |